Cronos Group, Inc. (CRON)
3.35
-0.02
(-0.59%)
USD |
NASDAQ |
Sep 18, 16:00
3.345
0.00 (0.00%)
After-Hours: 20:00
Cronos Group Price : 3.35 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 3.38 | 3.40 | 3.34 | 3.35 | 1.071M |
| Sep 17, 2026 | 3.33 | 3.41 | 3.31 | 3.37 | 748087.0 |
| Sep 16, 2026 | 3.22 | 3.37 | 3.22 | 3.29 | 1.052M |
| Sep 15, 2026 | 3.22 | 3.22 | 3.16 | 3.20 | 591461.0 |
| Sep 14, 2026 | 3.10 | 3.24 | 3.09 | 3.235 | 913268.0 |
| Sep 11, 2026 | 3.18 | 3.185 | 3.11 | 3.14 | 710828.0 |
| Sep 10, 2026 | 3.12 | 3.19 | 3.12 | 3.16 | 584730.0 |
| Sep 09, 2026 | 3.18 | 3.195 | 3.13 | 3.155 | 605773.0 |
| Sep 08, 2026 | 3.24 | 3.255 | 3.17 | 3.185 | 929831.0 |
| Sep 04, 2026 | 3.22 | 3.27 | 3.215 | 3.26 | 493811.0 |
| Sep 03, 2026 | 3.28 | 3.29 | 3.21 | 3.26 | 1.179M |
| Sep 02, 2026 | 3.36 | 3.40 | 3.23 | 3.24 | 855113.0 |
| Sep 01, 2026 | 3.34 | 3.42 | 3.33 | 3.38 | 1.116M |
| Aug 31, 2026 | 3.36 | 3.39 | 3.32 | 3.37 | 1.068M |
| Aug 28, 2026 | 3.40 | 3.421 | 3.31 | 3.38 | 1.239M |
| Aug 27, 2026 | 3.55 | 3.608 | 3.38 | 3.39 | 2.298M |
| Aug 26, 2026 | 3.49 | 3.58 | 3.48 | 3.55 | 1.421M |
| Aug 25, 2026 | 3.47 | 3.555 | 3.40 | 3.51 | 2.464M |
| Aug 24, 2026 | 3.31 | 3.45 | 3.27 | 3.41 | 2.217M |
| Aug 21, 2026 | 3.23 | 3.32 | 3.22 | 3.31 | 1.314M |
| Aug 20, 2026 | 3.275 | 3.299 | 3.21 | 3.22 | 998130.0 |
| Aug 19, 2026 | 3.21 | 3.30 | 3.21 | 3.29 | 1.375M |
| Aug 18, 2026 | 3.14 | 3.24 | 3.13 | 3.21 | 1.048M |
| Aug 17, 2026 | 3.14 | 3.18 | 3.12 | 3.15 | 1.331M |
| Aug 14, 2026 | 3.15 | 3.16 | 3.045 | 3.14 | 1.027M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Lexaria Bioscience Corp. | 3.24 |
| Target Group, Inc. (Canada) | 0.0008 |
| Tilray Brands, Inc. | 3.99 |
| InMed Pharmaceuticals, Inc. | 1.36 |
| XORTX Therapeutics, Inc. | 1.92 |
Price Related Metrics
| PE Ratio | 18.19 |
| PS Ratio | 7.129 |
| PEG Ratio | 0.0634 |
| Price to Book Value | 1.162 |
| Price to Free Cash Flow | 25.73 |
| Earnings Yield | 5.50% |
| Market Cap | 1.242B |
| PEGY Ratio | 0.0634 |
| Normalized PE Ratio | 16.92 |